Article: Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis.(Primary Care Approaches)

There are currently three leukotriene modifiers approved for use in the pediatric population. This paper will review the pathophysiology of asthma and allergic rhinitis and the associated family burden. The use of leukotriene modifiers for step-up management of asthma and allergic rhinitis as recommended by the National Heart, Lung, and Blood Institute's (NHLBI) National Asthma Education and Prevention Program (NAEPP), their action, dosing, side effects, and nursing implications will be reviewed.

Case Examples

E.B. is a 6-year-old female who presented to the clinic for a well child examination. Past medical history includes mild persistent asthma ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!